Cornea eye surgery
At our centre our surgeon is an expert corneal surgeon and has vast past experience of performing large number of corneal surgeries including Penetratring Keratoplasty[PK], Lemellar keratoplasty[LK], Deep Anterior lemellar Keratoplasty, DSEK etc. Very soon we are going to start our kratoplasty services once we get permission from Dept of health,Govt of Bihar.
Corneal Collagen Crosslinking with Riboflavin (C3-R®*) OR CXL
With current methods using rigid contact lens or intra corneal ring segments, only the refractive error (spectacle numbers) can be corrected, but it has very little effect on the progression of keratoconus. It is estimated that eventually 21% of the keratoconus patients require surgical intervention to restore corneal anatomy and eyesight. A new non surgical, non invasive treatment, based on collagen cross linking with Ultraviolet A (UVA, 365nm) and riboflavin (Vitamin B 2), a photosensitizing agent is now available. This changes the intrinsic biomechanical properties of the cornea, increasing its strength by almost 300%. This increase in corneal strength has shown to arrest the progression of keratoconus in numerous studies all over the world.
What is Collagen Cross-linking?
A treatment for keratoconus which has shown great success is Corneal Collagen Crosslinking with Riboflavin (C3-R®*) or CXL, a one-time application of riboflavin eye drops to the eye. The riboflavin, when activated by approximately 30 minutes illumination with UV-A light, augments the collagen cross-links within the stroma and so recovers some of the cornea’s mechanical strength. C3-R®*, developed at the Technische Universität Dresden, Germany has been shown to slow or arrest the progression of keratoconus, and in some cases even reverse it, particularly when applied in combination with intracorneal ring segments.
How is the treatment done?
The treatment is performed in our operation theatre under complete sterile conditions. Usually, only one eye is treated in one sitting. The treatment is performed under topical anesthesia (using anesthetic eye drops). The surface of the eye (cornea) is treated with application of Riboflavin eye drops for 30 minutes. The eye is then exposed to UVA light for 30 minutes. Hence, the treatment takes about an hour per eye. After the treatment, antibiotic eye drops are applied; a bandage contact lens may be applied, which will be removed by our doctor during the follow up visit. Protective eye wear, such as sunglasses (also given by us) is to be worn for a few days until complete healing takes place.
Who can benefit from this treatment?
Collagen cross-linking treatment is not a cure for keratoconus, rather, it aims to slow or even halt the progression of the condition. This is important to understand. Patients may need to continue to wear spectacles or contact lenses (although a change in the prescription may be required) following the cross-linking treatment but it is hoped that it could limit further deterioration in the patient’s vision and reduce the case for keratoplasty.The main aim of this treatment is to arrest progression of keratoconus, and thereby prevent further deterioration in vision and the need for corneal transplantation.
What are the risks and consequences involved?
Very few potential risks associated with this treatment have been reported so far. The Ultraviolet light dose used is designed to prevent damage to the cells that line the back of the cornea or the other structures within the eye. No lens opacities (cataracts) have been attributed to this treatment in European trials.
The treatment involves the outer layer (epithelium) of the cornea:
- There is therefore discomfort and a short-term haze.
- Other lesser but more common risks include:
- Inability to wear contact lenses for several weeks after the treatment
- Changes in corneal shape necessitates fitting of a contact lens or a occasional change in spectacle correction.
- As is the case with any treatment, there may also be long-term risks that have not yet been identified.
- The increased corneal rigidity induced may wear off over time and further periodic treatments may be required.
How does Cross Linking arrest keratoconus?
Until recently, there was no method to change the integrity and strength of the cornea itself for keratoconus patients. The non-invasive treatment C3-R®* (corneal collagen cross-linking riboflavin) treatment has been proven to strengthen the weak corneal structure in keratoconus. This method works by increasing collagen cross-linking, which are the natural “anchors” within the cornea. These anchors are responsible for preventing the cornea from >bulging out and becoming steep and irregular (which is the cause of keratoconus
The figures above show the parallel corneal layers (white) and the collagen cross-linking (red) which increased after C3-R®* treatment.
Are there any published studies for the same?
In published European studies, such treatments are proven safe and effective in patients. The 3 and 5 year results of Dresden clinical study in human eyes has shown arrest of progression of keratoconus in all treated eyes. (Wollensak G. Crosslinking treatment of progressive keratoconus: New Hope. Current Opinion in Ophthalmology 2006; 17: 356 – 360). Biomechanical measurements have shown an impressive increase in corneal rigidity of over 300% after crosslinking. The Dresden, Germany clinical study has shown that in all treated eyes the progression of keratoconus was stopped (‘freezing’). In over 53% of those eyes there was a slight reversal and flattening of the keratoconus by up to 2.87 diopters. Best corrected vision improved by 1.4 lines. This technique has shown great promise in treating early cases of the disease.
Advantages Of Cross Linking
- Simple- Single- one hour treatment
- No follow up sittings required
- No need for admission
- Stops the progress and causes regression of disease
- Does not need eye donation as in corneal transplant
- No major precautions
- No injections or stitches
- No incisions as in Intacs or Corneal ring segments
- Quick recovery with short follow up
A corneal ulcer is an open sore in the cornea. It is usually produced by an infection, commonly bacterial, fungal or viral. The ulcer can either be located in the centre of the cornea and greatly affect the vision or be placed in the periphery and not affect it so much. There are at least 25,000 cases of bacterial and fungal corneal ulcers each in India every year. Infections that develop in the cornea are frequently associated with trauma, contact lens overuse and dry eyes. It causes pain, redness and watering in the eye which can be quite severe. Ulcers frequently require 2-3 months of intensive treatment with eye drops and / or tablets and heal by corneal scarring. If visual loss occurs, this may require corneal grafting later in future. If medical treatment fails; intense suppuration )pus formation( often ensues, and the cornea can eventually perforate. Hence non healing ulcers may require therapeutic corneal grafting to save the eye
Fungal corneal infections frequently occur because of trauma with vegetable matter. Viral corneal infections often occur spontaneously or in immunocompromised patients. Collagen vascular disorders like rheumatoid arthritis and systemic diseases like tuberculosis, leprosy, syphilis, diabetes and AIDS can also cause corneal ulcers.
various degenerative conditions like band keratopathy, spheroidal degenerations, lipid keratopathy etc, can cause decrease in vision and require corneal grafting
These are hereditary disorders of cornea which cause excessive production of materials which get deposited in the cornea. If excessive, they can cause visual impairment requiring corneal grafting/ laser treatment )PTK( for vision improvement